2016
DOI: 10.1016/j.ijpddr.2016.11.001
|View full text |Cite
|
Sign up to set email alerts
|

The effect of the disulfideisomerase domain containing protein in the defense against polyhexamethylene biguanide of highly tolerant Acanthamoeba at the trophozoite stage

Abstract: Acanthamoeba castellanii is a free-living protozoan pathogen capable of causing a blinding keratitis and fatal granulomatous encephalitis. Current treatment generally involves an hourly application of polyhexamethylene biguanide (PHMB) over a period of several days but this is not entirely effective against all strains/isolates. The tolerance mechanisms of PHMB in Acanthamoeba cells remain unclear. In this study, we found that the mRNA expression level of disulfideisomerase domain containing protein (PDI) incr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
5

Relationship

3
2

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 26 publications
0
3
0
Order By: Relevance
“…Trophozoites were harvested at the logarithmic growth phase after cultivation for 3–5 days. The clinical isolates were isolated from the corneal ulcers of patients who were diagnosed with AK in the Cheng Kung University Hospital [ 3 , 17 , 37 ].…”
Section: Methodsmentioning
confidence: 99%
“…Trophozoites were harvested at the logarithmic growth phase after cultivation for 3–5 days. The clinical isolates were isolated from the corneal ulcers of patients who were diagnosed with AK in the Cheng Kung University Hospital [ 3 , 17 , 37 ].…”
Section: Methodsmentioning
confidence: 99%
“…However, the failure of topical treatments can occur due to the formation of amoebic cysts and disruption of the environment in the eye. Surgical options, including corneal transplantation, are necessary in the majority of AK cases to control the disease ( 7 ).…”
Section: Introductionmentioning
confidence: 99%
“… 4 , 5 Although numerous studies have been performed in an effort to improve the diagnosis and treatment of AK, 6 , 7 courses of topical anti-amoebic agents for up to 12 months remain the mainstay of treatment. 8 Unfortunately, because of drug resistance, 9 failure of topical medications is not uncommon, and PKP is still required in at least 25% of cases. 10 Therefore, novel treatments to enhance drug efficacy are needed to decrease the morbidity associated with AK.…”
Section: Introductionmentioning
confidence: 99%